Natural Alternatives says Court of Appeals rules in its favor in patent suit
Natural Alternatives International announced that the U.S. Court of Appeals for the Federal Circuit has ruled in NAI's favor, holding that its CarnoSyn beta-alanine patents are "patent eligible" under existing law. The Court's decision reverses a 2017 ruling by a California district court and revives important patent rights in NAI's existing patent portfolio. Mark LeDoux, NAI's CEO and Chairman of the Board, said that "NAI has always been confident that the Federal Circuit -- which has particular expertise in patent law -- would look at the body of science NAI put into the record, properly apply the law, and find NAI's patents are valid. That is what the Federal Circuit did in issuing its fact-based and carefully reasoned decision. As it has consistently done, NAI will continue to vigorously enforce its intellectual property rights."